Table 2.
Association between TET1 expression and clinical characteristics in NPC tissues
| Characteristics | Number (n = 33) | TET1 expression | p value | |||
|---|---|---|---|---|---|---|
| None | Low | Moderate | High | |||
| Age (years) | ||||||
| ≧ 48 | 16 | 2 | 9 | 4 | 1 | 0.778 |
| < 48 | 17 | 1 | 8 | 6 | 2 | |
| Gender | ||||||
| Female | 9 | 0 | 4 | 4 | 1 | 0.548 |
| Male | 24 | 3 | 13 | 6 | 2 | |
| WHO histological type | ||||||
| I (keratinizing) | 5 | 0 | 2 | 3 | 0 | 0.401 |
| II/III (non-keratinizing) | 28 | 3 | 15 | 7 | 3 | |
| Clinical stages | ||||||
| I | 6 | 1 | 4 | 1 | 0 | 0.255 |
| II | 13 | 1 | 8 | 4 | 0 | |
| III | 12 | 1 | 5 | 3 | 3 | |
| IV | 2 | 0 | 0 | 2 | 0 | |
| Lymph node metastasis | ||||||
| positive | 21 | 1 | 9 | 8 | 3 | 0.179 |
| negative | 12 | 2 | 8 | 2 | 0 | |